Products

IFF Pharma Solutions

Matching Products Categories (8)

98 Products found on IFF Pharma Solutions

With SDS
With TDS
POLYOX™ N60K LEO NF HV banner
IFF Pharma SolutionsPOLYOX™ N60K LEO NF HV
  • Chemical Name:Polyethylene Oxide, Polyethylene Glycol, Pyrogenic Silica
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Ethylene Glycol-free, Oxidatively Degradable, Irradiation-free, Animal Products-free, Dairy-free, Not Tested on Animals, Ethylene Oxide-free, Herbicide-free, Doping Substances-free, VOC-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ N60K LEO NF HV containing polyethylene oxide (PEG-45M) serves multiple functions in various applications. Its versatility extends to deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. Functioning as a thickener, binder, and controlled release agent, it ensures optimal formulation performance. Available in powder form, it exhibits water solubility, enhancing its usability in diverse pharmaceutical formulations.
POLYOX™ WSR - 303 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 303 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 303 FP NF Grade with its off-white powdered form, serves various functions in cleaning ingredients, acting as a binder and thickener. It finds application in diverse dosage forms such as gels, osmotic pump tablets, and conventional tablets, leveraging its water solubility and facilitating controlled release in pharmaceutical and nutraceutical formulations, manufactured through direct compression technology.
METHOCEL™ E6 Premium LV Capsule Grade HPMC banner
IFF Pharma SolutionsMETHOCEL™ E6 Premium LV Capsule Grade HPMC
  • INCI Name:Methylcellulose
  • Chemical Name:Hydroxypropyl Methylcellulose
  • CAS Number:9004-65-3
  • Dosage Form:Tablets, Capsules, Suspension
  • Labeling Claims:Phthalates-free, Steroids Free, Zero Calorie, Paraben-free, Nitrosamines-free, Aluminum-free, Preservative-free, Animal Products-free, Allergen-free, Residual Solvent -Free, Halal, Radioactive-free, Hypoallergenic, Potassium-free, PAH-free, Caffeine Free, Sewage Sludge Free, Colorants-free, Artificial Flavor-Free, Herbicide-free, NPE-free, PFOA-free, Diethylene Glycol-free, Gluten-free, PHO (Partially Hydrogenated Oil)-Free, Monosodium Glutamate (MSG)-free, VOC-free, TSE-free, Pareve, Endocrine Disruptor-free, Plant-Based, Quaternary Ammonium Salt-Free, Dioxin-free, Vegetarian, Non-GMO, Palm Oil-free, Ethylene Glycol-free, USP 232 Elemental Impurities Free, Kosher, Bisphenol A-free, PFAS-Free, Antibiotics-free, Hormones-free, PVC-free, Naturally Derived, Organic, Tributyltin (TBT) - Free, Bactericide-free, No Artificial Sweeteners, APE-free, Pesticide-free, Low Aldehyde, CMR Substances-free, Plasticizer-free, Irradiation-free, Glycerin-free, Sugar-free, PFOS-free, Fungicide-free, Perfluorocarbon (PFC)-free, BSE-free, Natural Latex Rubber-Free, Impurities-free, Vegan, Low Odor
METHOCEL™ E6 Premium LV Capsule Grade HPMC is a versatile product with various applications and functions. Ideal for tablet coating, granulation, wet granulation, tablets, and capsules, it ensures controlled and immediate release. Free from sewage sludge, it serves as a thickener, solubilizer, viscosity modifier, binder, film former, gelling agent, and mucoadhesive, making it indispensable in pharmaceutical and nutraceutical formulations. Suitable for food containers and packaging, it boasts water solubility, ensuring quality performance in suspension formulations.
POLYOX™ WSR - 301 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 301 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR - 301 FP NF Grade characterized by its off-white color, serves as a binder and thickener in cosmetic formulations. It is available in powder form and exhibits water solubility. Its versatility extends to various dosage forms including abuse deterrent tablets & capsules, gels, and osmotic pump tablets.
POLYOX™ WSR N 80NF TG LEO banner
IFF Pharma SolutionsPOLYOX™ WSR N 80NF TG LEO
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Heavy Metal-free, Kosher, Naturally Derived, Vegan, TSE-free, Diethylene Glycol-free, Allergen-free, Residual Solvent -Free, Plant-Based, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, No Added Formaldehyde, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, ICH Q3D, EC No. 1935/2004, ISO 9001, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, Halal, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), CFDA Compliant (China), Japan DMF, EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, Kosher, FFDCA, US DMF, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
  • Manufacturing Technology:Direct Compression
POLYOX™ WSR N 80NF TG LEO, in an off-white powder form, serves as a binder and thickener in cleaning and pharmaceutical formulations. Its water solubility makes it suitable for various applications, while its direct compression manufacturing technology ensures efficient production processes. Additionally, it functions as a controlled release agent, adding value to pharmaceutical formulations.
METHOCEL™ 10-0352 Cellulose Ether - Specialty banner
IFF Pharma SolutionsMETHOCEL™ 10-0352 Cellulose Ether - Specialty
  • INCI Name:Methylcellulose, Hydroxypropyl Methylcellulose
  • Chemical Family:Cellulose & Cellulosics, Cellulose Ethers
  • Dosage Form:Tablets
  • Labeling Claims:Phthalates-free, Steroids Free, Zero Calorie, Paraben-free, Nitrosamines-free, Aluminum-free, Preservative-free, Animal Products-free, Allergen-free, Residual Solvent -Free, Halal, Radioactive-free, Potassium-free, PAH-free, Caffeine Free, Sewage Sludge Free, Colorants-free, Artificial Flavor-Free, Herbicide-free, NPE-free, PFOA-free, Diethylene Glycol-free, Gluten-free, PHO (Partially Hydrogenated Oil)-Free, Monosodium Glutamate (MSG)-free, Dairy-free, VOC-free, TSE-free, Pareve, Aflatoxin-free, Endocrine Disruptor-free, Plant-Based, Quaternary Ammonium Salt-Free, Dioxin-free, Vegetarian, Non-GMO, Palm Oil-free, Ethylene Glycol-free, Mycotoxins-free, Kosher, Bisphenol A-free, PFAS-Free, Antibiotics-free, Hormones-free, PVC-free, Naturally Derived, Organic, Tributyltin (TBT) - Free, Bactericide-free, No Artificial Sweeteners, APE-free, Pesticide-free, CMR Substances-free, Plasticizer-free, Irradiation-free, Glycerin-free, Sugar-free, PFOS-free, Fungicide-free, Perfluorocarbon (PFC)-free, BSE-free, Natural Latex Rubber-Free, Impurities-free, Vegan, Low Odor
METHOCEL™ 10-0352 Cellulose Ether - Specialty is a versatile excipient used in pharmaceutical applications. It functions as a controlled release agent, immediate release agent, thickener, solubilizer, viscosity modifier, binder, film former, gelling agent, and mucoadhesive. Suitable for use in tablets, capsules, and suspensions, it is also effective in tablet coating, granulation, and wet granulation processes. This water-soluble cellulose ether offers benefits such as zero calorie content and low odor.
POLYOX™ WSR - N12K FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - N12K FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Thickener, Flocculant, Viscosity Modifier, Binder, Lubricant, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, Herbicide-free, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ WSR - N12K FP NF Grade composed of ethylene oxide copolymers and polyethylene oxide, serves diverse functions in pharmaceutical formulations. It finds application in abuse-deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. This versatile ingredient acts as a binder, thickener, and controlled release agent, ensuring optimal performance. Available in powder form, it demonstrates water solubility, facilitating easy integration into formulations for enhanced effectiveness.
POLYOX™ WSR - 205 FP NF Grade banner
IFF Pharma SolutionsPOLYOX™ WSR - 205 FP NF Grade
  • Chemical Name:Polyethylene Oxide
  • CAS Number:25322-68-3
  • Functions:Lubricant (Internal), Film Former, Flocculant, Binder, Controlled Release Agent
  • Dosage Form:Tablets, Abuse Deterrent Tablets & Capsules, Osmotic Pump Tablet, Gels
  • Labeling Claims:Chlorine-free, Nitrosamines-free, Vegetarian, Kosher, Vegan, TSE-free, Diethylene Glycol-free, Fungicide-free, Pesticide-free, Allergen-free, Residual Solvent -Free, Not Listed In California Proposition 65, Ethylene Glycol-free, Oxidatively Degradable, Animal Products-free, Dairy-free, Not Tested on Animals, Herbicide-free, Doping Substances-free, BSE-free, Halal, Non-GMO, Zinc-free, Gluten-free
  • Certifications & Compliance:Japan Pharmacopeia (JP), Directive 2002/95/EC, EC No. 1935/2004, ISO 9001, FDA Compliant, Belgian Law And Codex Alimentarius Standards, Directive 1333/2008/EC, European Pharmacopeia (Ph. Eur.), EU Packaging Directive (94/62/EC), Regulation (EU) No. 1935/2004, United States Pharmacopeia (USP), EC No.1907/2006, Regulation (EC) No. 338/97, Directive 2011/65/EU (RoHS 2), EU Cosmetic Regulation 1223/2009 Compliant, ICH Q3C, FFDCA, National Formulary (NF), EC No. 2023/2006, EXCiPACT, Generally Recognized As Safe (GRAS), Clean Water Act (CWA) Certified, Regulation (EU) No. 10/2011 (PIM), Regulation (EU) No. 1829/2003, Directive 2001/83/EC, Directive 2009/48/EC, British Pharmacopeia (BP), Directive 2023/2055/EU, Regulation (EU) No. 1272/2008, Chinese Pharmacopeia (ChP), EU Directive 2002/72/EC, GMP, Regulation (EU) No. 1830/2003
POLYOX™ WSR - 205 FP NF Grade comprising ethylene oxide copolymers and polyethylene oxide (PEG-14M), serves multiple functions across various pharmaceutical applications. Its versatility extends to deterrent tablets and capsules, gels, osmotic pump tablets, and regular tablets. Functioning as a binder and thickener, it ensures optimal formulation performance. Available in powder form, it exhibits water solubility, facilitating ease of use in pharmaceutical formulations.

Show

of 98 results